Aortic Endograft Global Market Report 2026

An aortic endograft, also known as an endovascular stent graft, is a minimally invasive medical device designed to repair weakened areas of the aorta, the primary artery responsible for transporting blood from the heart to the rest of the body. This device serves as an alternative to traditional open surgery for treating aortic aneurysms.

The primary categories of aortic endografts include abdominal aortic grafts and thoracic aortic grafts. Abdominal aortic grafts are specifically implanted in the abdominal aorta to address aneurysms by reinforcing weakened arterial walls. These devices can be made from materials such as metallic endografts and polymeric endografts, and the procedures involved include open surgical repair and endovascular aneurysm repair (EVAR). Aortic endografts are commonly utilized in medical settings, including hospitals and ambulatory surgical centers.

Tariffs are influencing the aortic endograft market by increasing costs of imported nitinol frameworks, polymer graft materials, precision manufacturing equipment, and delivery system components. Hospitals and vascular centers in North America and Europe are most affected due to dependence on imported high-value implants, while Asia-Pacific faces cost pressures on production and distribution. These tariffs are increasing procedure costs and procurement budgets. However, they are also encouraging regional manufacturing of vascular implants and strengthening local supply capabilities for endovascular devices.

The aortic endograft market research report is one of a series of new reports from The Business Research Company that provides aortic endograft market statistics, including aortic endograft industry global market size, regional shares, competitors with a aortic endograft market share, detailed aortic endograft market segments, market trends and opportunities, and any further data you may need to thrive in the aortic endograft industry. This aortic endograft market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aortic endograft market size has grown steadily in recent years. It will grow from $3.52 billion in 2025 to $3.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to rising incidence of aortic aneurysms, expansion of endovascular surgery adoption, improved imaging for vascular interventions, availability of advanced stent materials, increased surgeon expertise in minimally invasive techniques.

The aortic endograft market size is expected to see steady growth in the next few years. It will grow to $4.5 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to growing aging population with vascular disorders, rising preference for endovascular procedures, expansion of personalized vascular implants, increasing investments in next-generation graft materials, growing demand for faster recovery surgical options. Major trends in the forecast period include increasing adoption of minimally invasive aneurysm repair, rising use of fenestrated and branched endografts, growing demand for customized stent graft designs, expansion of evar procedures, enhanced focus on long-term graft durability.

The increasing prevalence of aortic aneurysms is expected to drive the growth of the aortic endograft market in the coming years. An aortic aneurysm refers to a localized and abnormal enlargement or bulging of the aorta, the largest artery in the human body. The rise in the prevalence of aortic aneurysms is attributed to the growing average age of the population along with the high incidence of related conditions such as hypertension and atherosclerosis. The expanding prevalence of aortic aneurysms supports the aortic endograft market by increasing demand for endovascular repair devices that offer minimally invasive alternatives to open surgery, lower procedural risks, and enhance patient recovery. For example, in February 2023, according to the Government Digital Service, a UK-based public sector information website, approximately 274,800 men were offered screening, with 79.0% receiving a conclusive result and 1,794 aneurysms identified. Therefore, the rising prevalence of aortic aneurysms is driving the growth of the aortic endograft market.

Key players in the aortic endograft market are developing innovative solutions, such as the castor-branched aortic stent graft system, to enhance their competitive position in the industry. The castor-branched aortic stent graft system is a medical device designed for minimally invasive repair of the aorta and aortic arch, particularly for Stanford type B aortic dissection (TBAD). For example, in August 2024, Terumo India, a significant medical technology company and the Indian subsidiary of Terumo Corporation, introduced the TREO Stent-Graft System, an innovative solution for Endovascular Aneurysm Repair (EVAR). This advanced system is intended for treating infrarenal abdominal aortic aneurysms in adults with suitable anatomies and is the only EVAR graft that provides both suprarenal and infrarenal active fixation.

In 2025, Terumo Aortic, a US-based manufacturer of aortic endograft devices, collaborated with Bentley to undertake a pioneering clinical study in the aortic endograft market. Through this partnership, Terumo Aortic and Bentley seek to strengthen clinical evidence, enhance device performance, and improve patient outcomes in complex aortic procedures. Terumo Aortic is known for its expertise in aortic and vascular solutions, while Bentley concentrates on innovative cardiovascular technologies and clinical research support. Bentley is a US-based manufacturer of cardiovascular technology and balloon-expandable covered stents.

Major companies operating in the aortic endograft market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., LifeTech Scientific Corporation, MicroPort Scientific Corporation, CryoLife Inc., Endologix LLC, Braile Biomedica Industria Comercio e Representacoes Ltda., Nano Endoluminal S.A., JOTEC GmbH, Lombard Medical Inc., Aptus Endosystems Inc., Lombardi SA, Cardiatis S.A., Endospan Ltd., Transcatheter Technologies GmbH, Vascutek Ltd.

North America was the largest region in the aortic endograft market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic endograft market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aortic endograft market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The aortic endograft market consists of revenues earned by entities by training programs, educational services, maintenance, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The aortic endograft market also includes sales of endoanchors and sealants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aortic Endograft Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses aortic endograft market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aortic endograft ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aortic endograft market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Abdominal Aortic Grafts; Thoracic Aortic Grafts
• 2) By Material: Metallic Endografts; Polymeric Endografts
• 3) By Procedure: Open Surgical Repair; Endovascular Aneurysm Repair (EVAR)
• 4) By End User: Hospitals; Ambulatory Surgical Centers
• Subsegments:
• 1) By Abdominal Aortic Grafts: Fenestrated Aortic Grafts; Branched Aortic Grafts; Conventional Aortic Grafts
• 2) By Thoracic Aortic Grafts: Stented Thoracic Aortic Grafts; Non-Stented Thoracic Aortic Grafts; Hybrid Thoracic Aortic Grafts
• Companies Mentioned: Abbott Laboratories; Medtronic Plc; Boston Scientific Corporation; Terumo Corporation; W. L. Gore & Associates Inc.; Cook Medical Inc.; LifeTech Scientific Corporation; MicroPort Scientific Corporation; CryoLife Inc.; Endologix LLC; Braile Biomedica Industria Comercio e Representacoes Ltda.; Nano Endoluminal S.A.; JOTEC GmbH; Lombard Medical Inc.; Aptus Endosystems Inc.; Lombardi SA; Cardiatis S.A.; Endospan Ltd.; Transcatheter Technologies GmbH; Vascutek Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.